Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Duodenal Neuroendocrine Tumor”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Study completedNCT01673906
What this trial is testing

68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours

Who this might be right for
Neuroendocrine Tumours
Azienda USL Reggio Emilia - IRCCS 142
Not applicableUnknownNCT06121752
What this trial is testing

Device Assisted Full Thickness Resection Versus Endoscopic Submucosal Dissection for Duodenal Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Asian Institute of Gastroenterology, India 54
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00454363
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer

Who this might be right for
Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+8 more
National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Study completedNCT02420691
What this trial is testing

Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin

Who this might be right for
Advanced Digestive System Neuroendocrine NeoplasmDuodenal Neuroendocrine Tumor G1Functional Pancreatic Neuroendocrine Tumor+5 more
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT05641233
What this trial is testing

Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After Pancreatoduodenectomy

Who this might be right for
Neuroendocrine Carcinoma of PancreasDuodenum CarcinomaPancreas Neoplasm+4 more
Erasmus Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Not applicableStudy completedNCT06790056
What this trial is testing

Efficacy of Endoscopic Band Ligation (DEBL) for Duodenal Neuroendocrine Neoplasms(dNENs)

Who this might be right for
Duodenal Neuroendocrine Tumor
Asian Institute of Gastroenterology, India 50
Testing effectiveness (Phase 2)Study completedNCT00869050
What this trial is testing

Capecitabine and Temozolomide for Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Tumors
Columbia University 41
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableLooking for participantsNCT07328607
What this trial is testing

Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy

Who this might be right for
Pancreatic Ductal AdenocarcinomaAmpullary CarcinomaDistal Cholangiocarcinoma+2 more
Minia University 90
Testing effectiveness (Phase 2)Looking for participantsNCT06333314
What this trial is testing

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Who this might be right for
Pancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more
UNICANCER 120
Testing effectiveness (Phase 2)Ended earlyNCT05251233
What this trial is testing

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Who this might be right for
Pancreatic CancerPancreas CancerAmpullary Cancer+4 more
Washington University School of Medicine 56
Early research (Phase 1)Study completedNCT01204476
What this trial is testing

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

Who this might be right for
Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more
National Cancer Institute (NCI) 27